• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The kids are alright: MDS clones mature.

作者信息

Rao Sridhar

机构信息

Versiti Blood Research Institute.

Medical College of Wisconsin.

出版信息

Blood. 2023 Mar 16;141(11):1243-1245. doi: 10.1182/blood.2022019187.

DOI:10.1182/blood.2022019187
PMID:36929441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10163310/
Abstract
摘要

相似文献

1
The kids are alright: MDS clones mature.孩子们情况良好：骨髓增生异常综合征克隆成熟。
Blood. 2023 Mar 16;141(11):1243-1245. doi: 10.1182/blood.2022019187.
2
[Study of the clonal origin and development of MDS by FISH analysis of dysplasia cells in bone marrow of patients with MDS].[通过对骨髓增生异常综合征（MDS）患者骨髓发育异常细胞进行荧光原位杂交（FISH）分析研究MDS的克隆起源与发展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):650-6. doi: 10.7534/j.issn.1009-2137.2013.03.023.
3
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes.克隆战争：骨髓增生异常综合征中IDH2 R140Q和R172K的共现
Ann Hematol. 2020 Apr;99(4):891-893. doi: 10.1007/s00277-020-03913-x. Epub 2020 Feb 4.
4
Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.骨髓增生异常综合征患者中的阵发性夜间血红蛋白尿克隆
Br J Haematol. 1998 Jul;102(2):465-74. doi: 10.1046/j.1365-2141.1998.00794.x.
5
Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.119 例范可尼贫血患者中骨髓增生异常综合征的诊断：形态学和细胞遗传学特征。
Am J Clin Pathol. 2010 Jan;133(1):92-100. doi: 10.1309/AJCP7W9VMJENZOVG.
6
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.使用循环肿瘤 DNA 进行骨髓增生异常综合征的分子疾病监测。
Blood. 2017 Mar 23;129(12):1685-1690. doi: 10.1182/blood-2016-09-740308. Epub 2017 Jan 26.
7
High concordance of clone detection between peripheral blood and bone marrow by targeted next-generation sequencing-A pilot study in patients with MDS.
Br J Haematol. 2023 Aug;202(3):e16-e19. doi: 10.1111/bjh.18889. Epub 2023 Jun 1.
8
Transient myelodysplastic syndrome associated with isochromosome 7q abnormality.与7号染色体长臂等臂异常相关的短暂性骨髓增生异常综合征
Pediatr Hematol Oncol. 2003 Oct-Nov;20(7):539-45. doi: 10.1080/08880010390232754.
9
inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.急性髓系白血病/骨髓增生异常综合征中inv(3)(q21q26)：采用间期荧光原位杂交技术监测恶性克隆
Haematologica. 2003 Dec;88(12):ECR38.
10
Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases.治疗相关的骨髓增生异常综合征和急性髓系白血病中细胞遗传学不相关的克隆：哥本哈根系列研究更新至180例连续病例的经验
Genes Chromosomes Cancer. 1998 Dec;23(4):337-49. doi: 10.1002/(sici)1098-2264(199812)23:4<337::aid-gcc9>3.0.co;2-l.

引用本文的文献

1
Disruption of normal stem cell function and transmission of myelodysplastic syndrome by self-renewal of committed myeloid lineage cells.定向髓系谱系细胞的自我更新导致正常干细胞功能破坏及骨髓增生异常综合征的传递。
Stem Cell Reports. 2025 Aug 12;20(8):102571. doi: 10.1016/j.stemcr.2025.102571. Epub 2025 Jul 3.

本文引用的文献

1
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy.MDS 和 CMML 中突变性 HSC 克隆对幼稚细胞和成熟细胞的贡献，以及与 AZA 治疗的变化。
Blood. 2023 Mar 16;141(11):1316-1321. doi: 10.1182/blood.2022018602.
2
The longitudinal dynamics and natural history of clonal haematopoiesis.克隆性造血的纵向动力学和自然史。
Nature. 2022 Jun;606(7913):335-342. doi: 10.1038/s41586-022-04785-z. Epub 2022 Jun 1.
3
Clonal dynamics of haematopoiesis across the human lifespan.人类生命全程中的造血克隆动力学。
Nature. 2022 Jun;606(7913):343-350. doi: 10.1038/s41586-022-04786-y. Epub 2022 Jun 1.
4
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.CCUS与低风险骨髓增生异常综合征之间的临床、分子及预后比较：一项对187例分子注释患者的研究
Blood Adv. 2021 Apr 27;5(8):2272-2278. doi: 10.1182/bloodadvances.2020003976.
5
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.慢性髓性白血病：现代疗法、当前挑战与未来方向。
Blood Rev. 2021 Sep;49:100825. doi: 10.1016/j.blre.2021.100825. Epub 2021 Mar 16.
6
Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations.可测量残留病作为急性髓细胞白血病的生物标志物：理论与实际考虑。
Leukemia. 2021 Jun;35(6):1529-1538. doi: 10.1038/s41375-021-01230-4. Epub 2021 Mar 23.
7
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.意义未明的克隆性血细胞减少症的治疗结果：一项单机构回顾性研究。
Blood Cancer J. 2021 Mar 1;11(3):43. doi: 10.1038/s41408-021-00439-x.
8
Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes.综合基因组学鉴定骨髓增生异常综合征中阿扎胞苷治疗耐药的分子基础。
Cell Rep. 2017 Jul 18;20(3):572-585. doi: 10.1016/j.celrep.2017.06.067.
9
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.在对去甲基化药物有反应的慢性粒单核细胞白血病中，突变等位基因负担保持不变。
Nat Commun. 2016 Feb 24;7:10767. doi: 10.1038/ncomms10767.